Taking higher doses may also bring an increased risk of these side effects
The challenge with upper arm self-injection is access
It produces greater weight loss (approximately 10-12% even in diabetic patients, who typically lose less than non-diabetics), provides excellent blood sugar control (HbA1c reductions of 1.0-1.8 percentage points), and has proven cardiovascular protection (especially important since diabetes increases cardiovascular risk)
At Southern Urogynecology Wellness and Aesthetics, we understand the reality of these struggles, and were here to offer a different kind of support
Clinical Trial Evidence and Findings in Female Participants Phase 2 trial data (Jastreboff et al., NEJM, 2023) showed dose-dependent weight reduction and metabolic improvements, but sex-disaggregated results were not published, so female-specific efficacy cannot yet be confirmed